Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc. The global average gross margin of specialty drug distribution is in the decreasing trend, from 7.85% in 2011 to5.97% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years. The type of specialty drugs includes oncology, rheumatoid arthritis, multiple sclerosis, hemophilia and others. The proportion of oncology drugs in 2015 is about 45.8%, and the proportion of rheumatoid arthritis drug in 2015 is about 15.4%. Specialty drugs are widely sold by retail, home health, clinics, and pharmacies. The most proportion of specialty drugs are sold by clinics and the market share in 2015 is about 37.6%. North America region is the largest supplier of specialty drug distribution, with a sales revenue market share nearly 45.6% in 2015. Europe is the second largest supplier of specialty drug distribution, enjoying sales revenue market share about 31.7% in 2015. Market competition is intense between the giant, Amerisource, Mckesson, Cardinal Health, etc. are the leaders of the industry in North America, PHOENIX, Alliance Healthcare, Celesio, etc. are the leaders of the industry in Europe and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Specialty Drug Distribution market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Specialty Drug Distribution industry. Based on our recent survey, we have several different scenarios about the Specialty Drug Distribution YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 813.9 million in 2019. The market size of Specialty Drug Distribution will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Specialty Drug Distribution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Specialty Drug Distribution market in terms of revenue. Players, stakeholders, and other participants in the global Specialty Drug Distribution market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Specialty Drug Distribution market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Specialty Drug Distribution market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Specialty Drug Distribution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Specialty Drug Distribution market. The following players are covered in this report: Amerisource Mckesson Cardinal Health PHOENIX Medipal Holdings Alliance Healthcare Celesio Sinopharm Accredo Shanghai Pharma Anda Jointown Max Pharma Avella Specialty Drug Distribution Breakdown Data by Type Oncology Rheumatoid Arthritis Multiple Sclerosis Hemophilia Specialty Drug Distribution Breakdown Data by Application Retail Home Health Clinics Pharmacies
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Specialty Drug Distribution Revenue 1.4 Market Analysis by Type 1.4.1 Global Specialty Drug Distribution Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Oncology 1.4.3 Rheumatoid Arthritis 1.4.4 Multiple Sclerosis 1.4.5 Hemophilia 1.5 M
